DOVE CLINICAL PROTECTION COOL ENERGIZING ANTIPERSPIRANT AND - America[美国药品]

TOP

DOVE CLINICAL PROTECTION COOL ENERGIZING ANTIPERSPIRANT AND

2014-03-02 19:11:37 来源: 作者: 【大中小】浏览:493次评论:0条

Active Ingredient

Aluminum Zirconium Tetrachlorohydrex GLY (20%)

Purpose
anti-perspirant

Uses
· reduces underarm wetness
· 24 hour protection
· extra effective

Warnings
For external use only

Do not use on broken skin

Ask a doctor before use if you have kidney disease

Stop use if rash or irritation occurs

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions
· apply to underarms only
· before bed, apply three clicks of product to each underarm

Cyclopentasiloxane, Dimethicone, PPG-14 Butyl Ether, Paraffin, Microcrystalline Wax, Fragrance (Parfum), Silica, Helianthus Annuus (Sunflower) Seed Oil, Dimethicone Crosspolymer,BHT.

Questions? Call toll-free 1-800-761-DOVE

1.7 oz PDP

Dove Clinical Protection Energizing 1.7 oz PDP

PDP 1.7 oz carton

Dove Clinical Protection Energizing 1.7 oz Carton PDP

DOVE CLINICAL PROTECTION COOL ENERGIZING ANTIPERSPIRANT AND DEODORANT
aluminum zirconium tetrachlorohydrex gly stick

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:64942-1073
Route of Administration	TOPICAL	DEA Schedule

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
Aluminum Zirconium Tetrachlorohydrex GLY (Aluminum cation)	Aluminum Zirconium Tetrachlorohydrex GLY	20g in100g

Inactive Ingredients
Ingredient Name	Strength
CYCLOMETHICONE 5
DIMETHICONE
PPG-14 BUTYL ETHER
PARAFFIN
MICROCRYSTALLINE WAX
SILICON DIOXIDE
SUNFLOWER OIL
BUTYLATED HYDROXYTOLUENE

Product Characteristics
Color		Score
Shape		Size
Flavor		Imprint Code
Contains

Packaging
#	Item Code	Package Description	Multilevel Packaging
1	NDC:64942-1073-2	1 CONTAINER ( CONTAINER) in 1 CARTON	contains a CONTAINER(64942-1073-1)
1	NDC:64942-1073-1	48 g in 1 CONTAINER	This package is contained within the CARTON(64942-1073-2)

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part350	09/07/2011